Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro - Poll - MDSpire

Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro

  • By

  • Manoj S Nair

  • Maria I Luck

  • Yaoxing Huang

  • Yosef Sabo

  • David D Ho

  • August 12, 2024

  • 0 min

Share

Original Source(s)

Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cells In Vitro

  • by Manoj S Nair, Maria I Luck, Yaoxing Huang, Yosef Sabo, David D Ho

  • August 12, 2024

Related Content

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Multi-omics analysis of long COVID (post-COVID-19 condition) reveals persistent mitochondrial dysfunction, suppressed oxidative phosphorylation, and immune dysregulation

Impact of COVID-19 history on the prevalence of coronary slow flow: a comparative study in unstable angina patients